Eric Karas

Insider Reports History

Entity
Individual
Location
C/O Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Karas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 5.69K $79.7K $14.00 Sep 18, 2024 Direct
ARS Pharmaceuticals, Inc. Chief Commercial Officer Stock Option (Right to Buy) 595K Sep 18, 2024 Direct

Insider Reports Filed by Eric Karas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY ARS Pharmaceuticals, Inc. Sep 18, 2024 3 -$125K 4 Sep 19, 2024 Chief Commercial Officer
SPRY ARS Pharmaceuticals, Inc. Aug 19, 2024 3 -$125K 4 Aug 21, 2024 Chief Commercial Officer
SPRY ARS Pharmaceuticals, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Commercial Officer
SPRY ARS Pharmaceuticals, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Commercial Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 1 $0 4 Nov 10, 2022 Chief Commercial Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Chief Commercial Officer